期刊文献+

年轻妇女卵巢恶性肿瘤临床分析

Analysis of ovarian malignancies in young women
下载PDF
导出
摘要 目的:探讨年轻妇女卵巢恶性肿瘤的临床特点。方法:回顾性分析10年间收治的年轻妇女卵巢恶性肿瘤患者(年龄〈40岁)的临床资料。结果:27例年轻妇女卵巢恶性肿瘤患者的中位年龄30岁(13-39岁);5年总生存率51.72%,生存时间5月-119月,平均生存期71月。结论:年轻妇女卵巢恶性肿瘤患者预后相对较好。 Objective: To investigate the clinical characteristics of ovarian malignancies in young women. Methods: The clinical data of 27 young women (age〈40 yeats) with ovarian malignancies were analyzed retrospectively. Results: The median age of 27 young women was 30 years (range 13-39 years) .The 5-years overall survival rate was 51.72%, the mean survival time was 71 months (range 5-119 months) . Conclusion: In these data, the young women with ovarian malignancies have comparatively preferable prognosis.
出处 《中国妇幼保健》 CAS 北大核心 2008年第7期904-905,共2页 Maternal and Child Health Care of China
关键词 卵巢肿瘤 治疗 预后 年轻妇女 临床分析 Ovarian neoplasm Therapy Prognosis Young women Clinical analysis
  • 相关文献

参考文献6

二级参考文献29

  • 1[1]Griffiths CT.Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma[J].Natl Cancer Inst Monogr,1975,42:101-104
  • 2[2]Hoskins WJ,McGuire WP,Brady MF,et al.The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma[J].Am J Obstet Gynecol,1994,170:974-80
  • 3[3]Maghaddam A,Zhang HT,Fan TPD,et al.Thymidine phosphorylase is angiogenic and promotes tumour growth[J].Proc Natl Acad Sci USA,1995,92:998-1002
  • 4[4]Yamamoto S,Konishi I,Mandai M,et al.Expression of vascular endothelial growth factor(VEGF) in epithelial ovarian neoplasms:Correlation with clinical pathology and patient survival,and analysis of serum VEGF levels[J].Br J Pathol,1997,76:1221-1227
  • 5[5]Chen CHA,Cheng WF,Lee CHN,et al.Serum vascular endothelialgrowth factor in epithelial ovarian neoplasms:Correlation with patient survival[J].Gynecol Oncol,1999,74:235-240
  • 6[6]Hata K,Kamikawa T,Arao S,et al.Expression of the thymidine phosphorylase gene in epithelial ovarian cancer[J].Br J Cancer,1999,79:1848-1854
  • 7[7]Mesiano S,Ferrara N,Jaffe RB.Role of vascular endothelial growthfactor in ovarian cancer[J].Am J Pathol,1998,153:1249-1256
  • 8[8]Brustmann H,Riss P,Naude S.The relevance of angiogenesis in benign and malignant epithelial tumors of the ovary:A quantitative histologic study[J].Gynecol Oncol,1997,67:20-26
  • 9[9]Abulafia O,Ruiz J,Holcomb K,et al.Angiogenesis in early invasiveand low malignat potential epithelial ovarian carcinoma[J].Obstet Gynecol,2000,95:548-552
  • 10Williams S,Blessing JA,Liao SY,et al.Adjuvant therapy of ovarian germ cell tumors with cisplatin,etoposide,and bleomycin:a trial of the Gynecologic Oncology Group.J Clin Oncol,1994,12:701-706.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部